Skip to main content

Table 2 Results of ROC analysis separated by stage

From: Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin’s lymphoma

 

Stage I/II

Stage III/IV

AUC (95%-CI)

Optimal cut-off value

AUC (95%-CI)

Optimal cut-off value

Metabolic parameters

 MTV

0.84 (0.69 to 0.99)

> 80 ml

0.86 (0.7 to 1.0)

> 410 ml

 SUVmax

0.56 (0.33 to 0.8)

> 10.2

0.71 (0.5 to 0.93)

> 13.8

 SUVmean

0.61 (0.39 to 0.83)

> 4.1

0.71 (0.5 to 0.93)

> 5.9

 SUVpeak

0.58 (0.35 to 0.81)

> 9.1

0.74 (0.53 to 0.95)

> 12.6

 TLG

0.77 (0.58 to 0.97)

> 450 ml

0.86 (0.7 to 1.0)

> 2800 ml

Heterogeneity parameters

 ASP

0.65 (0.43 to 0.88)

> 92%

0.74 (0.54 to 0.95)

> 210%

 Entropy

0.58 (0.35 to 0.81)

< 5.82

0.58 (0.33 to 0.82)

< 5.73

 Contrast

0.67 (0.45 to 0.89)

< 25

0.66 (0.43 to 0.89)

< 16

 Local homogeneity

0.58 (0.33 to 0.83)

> 24

0.68 (0.45 to 0.91)

> 30.4

 Energy

0.58 (0.34 to 0.82)

> 0.394

0.55 (0.31 to 0.8)

> 0.51

 CSH

0.49 (0.25 to 0.74)

> 0.44

0.46 (0.21 to 0.7)

> 0.44

  1. MTV metabolic tumor volume, 95%-CI 95%-confidence interval, TLG total lesion glycolysis, ASP asphericity, CSH cumulative SUV-volume histograms